Cardinal Health, Inc. (CAH) Downgraded by Vetr Inc. to "Hold"
They presently have a $76.99 price objective on the stock. Vetr 's target price would suggest a potential upside of 3.37% from the company's previous close.
from Biotech News
They presently have a $76.99 price objective on the stock. Vetr 's target price would suggest a potential upside of 3.37% from the company's previous close.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments